Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects

NCT00706797 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: etanercept (EnbrelTM)
DRUG: methotrexate

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer